Is Trevi Therapeutics, Inc. (TRVI) a Buy, Sell, or Hold?
NASDAQ : TRVI
Trevi Therapeutics, Inc.
$19.52 USD
$2.16 (12.44%)
- Volume
- 5.14M
- Average Volume
- 2.02M
- Market Capitalization
- $2.77B
- P/E Ratio
- -60.58
- Dividend Yield
- 0.00%
- Price Target
- $25.00
- Year High
- $20.15
- Year Low
- $6.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $24.75
Insider Activity Summary (Last 12 Months)
Insiders Buying
22
Insiders Selling
9
Amount of Insider Selling
$14.82M
TRVI Insider Buying/Selling by Quarter
TRVI Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Mathers Edward T | director | 2026-06-03 | A-Award | 13.45 | 2026-06-04 |
| Colangelo Dominick | director | 2026-06-03 | A-Award | 13.45 | 2026-06-04 |
| Meeker David P | director | 2026-06-03 | A-Award | 13.45 | 2026-06-04 |
| VANLENT ANNE | director | 2026-06-03 | A-Award | 13.45 | 2026-06-04 |
| Heffernan Michael Thomas | director | 2026-06-03 | A-Award | 13.45 | 2026-06-04 |
| Cassella James V | officer: Chief Development Officer | 2026-02-19 | A-Award | 10.56 | 2026-02-20 |
| Galletta Christopher | officer: See Remarks | 2026-02-19 | A-Award | 10.56 | 2026-02-20 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2026-02-19 | A-Award | 10.56 | 2026-02-20 |
| GOOD JENNIFER L | director, officer: President & CEO | 2026-02-19 | A-Award | 10.56 | 2026-02-20 |
| Simon Farrell | officer: Chief Commercial Officer | 2026-02-19 | A-Award | 10.56 | 2026-02-20 |
| SANDELL SCOTT D | 10 percent owner | 2025-12-31 | 0 | 2026-02-13 | |
| Florence Anthony A. Jr. | 10 percent owner | 2025-12-31 | 0 | 2026-02-13 | |
| Florence Anthony A. Jr. | 10 percent owner | 2025-04-17 | X-InTheMoney | 1.37 | 2026-02-13 |
| SANDELL SCOTT D | 10 percent owner | 2025-04-17 | X-InTheMoney | 1.37 | 2026-02-13 |
| Behbahani Ali | 10 percent owner | 2025-12-31 | 0 | 2026-02-13 | |
| Behbahani Ali | 10 percent owner | 2025-04-17 | X-InTheMoney | 1.37 | 2026-02-13 |
| BASKETT FOREST | 10 percent owner | 2025-04-17 | X-InTheMoney | 1.37 | 2026-02-13 |
| Makhzoumi Mohamad | 10 percent owner | 2025-12-31 | 0 | 2026-02-13 | |
| Makhzoumi Mohamad | 10 percent owner | 2025-04-17 | X-InTheMoney | 1.37 | 2026-02-13 |
| Walker Paul Edward | 10 percent owner | 2025-12-31 | 0 | 2026-02-13 | |
| Walker Paul Edward | 10 percent owner | 2025-04-17 | X-InTheMoney | 1.37 | 2026-02-13 |
| New Enterprise Associates 16, L.P. | 10 percent owner | 2025-04-17 | X-InTheMoney | 1.37 | 2026-02-13 |
| Chang Carmen | 10 percent owner | 2025-12-31 | 0 | 2026-02-13 | |
| Chang Carmen | 10 percent owner | 2025-04-17 | X-InTheMoney | 1.37 | 2026-02-13 |
| HASTINGS DAVID C | officer: Chief Financial Officer | 2026-01-08 | A-Award | 11.21 | 2026-01-12 |
| HASTINGS DAVID C | 2026-01-08 | 0 | 2026-01-12 | ||
| Galletta Christopher | officer: See Remarks | 2025-12-02 | M-Exempt | 0.511 | 2025-12-03 |
| Galletta Christopher | officer: See Remarks | 2025-12-02 | M-Exempt | 0.511 | 2025-12-03 |
| Mathers Edward T | director | 2025-06-11 | A-Award | 6.25 | 2025-06-13 |
| Colangelo Dominick | director | 2025-06-11 | A-Award | 6.25 | 2025-06-13 |
| Heffernan Michael Thomas | director | 2025-06-11 | A-Award | 6.25 | 2025-06-13 |
| VANLENT ANNE | director | 2025-06-11 | A-Award | 6.25 | 2025-06-13 |
| Meeker David P | director | 2025-06-11 | A-Award | 6.25 | 2025-06-13 |
| Galletta Christopher | officer: See Remarks | 2025-05-31 | A-Award | 2.38 | 2025-06-03 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2025-05-31 | A-Award | 2.38 | 2025-06-03 |
| Delfini Lisa | officer: Chief Financial Officer | 2025-05-31 | A-Award | 2.38 | 2025-06-03 |
| Simon Farrell | officer: Chief Commercial Officer | 2025-05-31 | A-Award | 2.38 | 2025-06-03 |
| GOOD JENNIFER L | director, officer: President & CEO | 2025-05-31 | A-Award | 2.38 | 2025-06-03 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2025-03-25 | M-Exempt | 1.43 | 2025-03-26 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2025-03-25 | S-Sale | 6.6 | 2025-03-26 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2025-03-25 | M-Exempt | 1.43 | 2025-03-26 |
| GOOD JENNIFER L | director, officer: President & CEO | 2025-03-21 | M-Exempt | 1.43 | 2025-03-25 |
| GOOD JENNIFER L | director, officer: President & CEO | 2025-03-21 | S-Sale | 6.5789 | 2025-03-25 |
| GOOD JENNIFER L | director, officer: President & CEO | 2025-03-21 | M-Exempt | 1.43 | 2025-03-25 |
| GOOD JENNIFER L | director, officer: President & CEO | 2025-03-10 | A-Award | 2.38 | 2025-03-12 |
| Delfini Lisa | officer: Chief Financial Officer | 2025-03-10 | A-Award | 2.38 | 2025-03-12 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2025-03-10 | A-Award | 2.38 | 2025-03-12 |
| Galletta Christopher | officer: See Remarks | 2025-03-10 | A-Award | 2.38 | 2025-03-12 |
| Simon Farrell | officer: Chief Commercial Officer | 2025-03-10 | M-Exempt | 0.511 | 2025-03-12 |
| Simon Farrell | officer: Chief Commercial Officer | 2025-03-10 | M-Exempt | 3.91 | 2025-03-12 |
| Simon Farrell | officer: Chief Commercial Officer | 2025-03-10 | S-Sale | 6.7276 | 2025-03-12 |
| Simon Farrell | officer: Chief Commercial Officer | 2025-03-10 | S-Sale | 7.1498 | 2025-03-12 |
| Simon Farrell | officer: Chief Commercial Officer | 2025-03-10 | M-Exempt | 3.21 | 2025-03-12 |
| Simon Farrell | officer: Chief Commercial Officer | 2025-03-10 | A-Award | 2.38 | 2025-03-12 |
| Simon Farrell | officer: Chief Commercial Officer | 2025-03-10 | M-Exempt | 0.511 | 2025-03-12 |
| Simon Farrell | officer: Chief Commercial Officer | 2025-03-10 | M-Exempt | 3.91 | 2025-03-12 |
| Simon Farrell | officer: Chief Commercial Officer | 2025-03-10 | M-Exempt | 3.21 | 2025-03-12 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2025-02-18 | A-Award | 4.22 | 2025-02-20 |
| Cassella James V | officer: Chief Development Officer | 2025-02-18 | A-Award | 4.22 | 2025-02-20 |
| Simon Farrell | officer: Chief Commercial Officer | 2025-02-18 | A-Award | 4.22 | 2025-02-20 |
| Delfini Lisa | officer: Chief Financial Officer | 2025-02-18 | A-Award | 4.22 | 2025-02-20 |
| GOOD JENNIFER L | director, officer: President & CEO | 2025-02-18 | A-Award | 4.22 | 2025-02-20 |
| Galletta Christopher | officer: See Remarks | 2025-02-18 | A-Award | 4.22 | 2025-02-20 |
| Delfini Lisa | officer: Chief Financial Officer | 2025-01-08 | M-Exempt | 0.511 | 2025-01-10 |
| Delfini Lisa | officer: Chief Financial Officer | 2025-01-07 | M-Exempt | 0.511 | 2025-01-10 |
| Delfini Lisa | officer: Chief Financial Officer | 2025-01-07 | M-Exempt | 0.511 | 2025-01-10 |
| Delfini Lisa | officer: Chief Financial Officer | 2025-01-08 | M-Exempt | 0.511 | 2025-01-10 |
| Galletta Christopher | officer: See Remarks | 2024-12-13 | M-Exempt | 0.511 | 2024-12-17 |
| Galletta Christopher | officer: See Remarks | 2024-12-13 | M-Exempt | 0.511 | 2024-12-17 |
| Cassella James V | officer: Chief Development Officer | 2024-09-30 | A-Award | 3.34 | 2024-10-01 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-06 | M-Exempt | 1.43 | 2024-09-09 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-09 | M-Exempt | 1.43 | 2024-09-09 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-06 | S-Sale | 3.0302 | 2024-09-09 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-09 | S-Sale | 3.0362 | 2024-09-09 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-06 | M-Exempt | 1.43 | 2024-09-09 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-09 | M-Exempt | 1.43 | 2024-09-09 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-05 | M-Exempt | 1.43 | 2024-09-05 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-04 | M-Exempt | 1.43 | 2024-09-05 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-03 | M-Exempt | 1.43 | 2024-09-05 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-05 | S-Sale | 3.1112 | 2024-09-05 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-03 | S-Sale | 3.0229 | 2024-09-05 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-04 | S-Sale | 3.0239 | 2024-09-05 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-03 | M-Exempt | 1.43 | 2024-09-05 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-04 | M-Exempt | 1.43 | 2024-09-05 |
| GOOD JENNIFER L | director, officer: President & CEO | 2024-09-05 | M-Exempt | 1.43 | 2024-09-05 |
| Meeker David P | director | 2024-08-27 | M-Exempt | 1.43 | 2024-08-29 |
| Meeker David P | director | 2024-08-27 | S-Sale | 2.9314 | 2024-08-29 |
| Meeker David P | director | 2024-08-27 | M-Exempt | 1.43 | 2024-08-29 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-19 | M-Exempt | 1.43 | 2024-08-21 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-19 | S-Sale | 2.9633 | 2024-08-21 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-19 | M-Exempt | 1.43 | 2024-08-21 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-16 | M-Exempt | 1.43 | 2024-08-16 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-15 | M-Exempt | 1.43 | 2024-08-16 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-14 | M-Exempt | 1.43 | 2024-08-16 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-15 | S-Sale | 2.7864 | 2024-08-16 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-16 | S-Sale | 2.7567 | 2024-08-16 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-14 | S-Sale | 2.75 | 2024-08-16 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-14 | M-Exempt | 1.43 | 2024-08-16 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-15 | M-Exempt | 1.43 | 2024-08-16 |
| SCIASCIA THOMAS | officer: Chief Scientific Officer | 2024-08-16 | M-Exempt | 1.43 | 2024-08-16 |